HSBC Holdings’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.5M | Buy |
66,600
+53,500
| +408% | +$19.1M | 0.01% | 699 |
|
|
2025
Q4 | $4.3M | Buy |
+13,100
| New | +$4.16M | ﹤0.01% | 1270 |
|
|
2025
Q1 | – | Sell |
-29,900
| Closed | -$7.77M | – | 3023 |
|
|
2024
Q4 | $7.77M | Buy |
29,900
+100
| +0.3% | +$29.7K | ﹤0.01% | 1007 |
|
|
2024
Q3 | $9.57M | Buy |
29,800
+16,000
| +116% | +$5.23M | 0.01% | 932 |
|
|
2024
Q2 | $4.32M | Sell |
13,800
-21,400
| -61% | -$6.29M | ﹤0.01% | 1101 |
|
|
2024
Q1 | $10M | Sell |
35,200
-83,100
| -70% | -$24.3M | 0.01% | 879 |
|
|
2023
Q4 | $34M | Buy |
118,300
+50,800
| +75% | +$13.8M | 0.03% | 521 |
|
|
2023
Q3 | $18.1M | Buy |
67,500
+1,300
| +2% | +$324K | 0.02% | 658 |
|
|
2023
Q2 | $14.7M | Sell |
66,200
-11,900
| -15% | -$2.76M | 0.01% | 706 |
|
|
2023
Q1 | $18.7M | Sell |
78,100
-84,700
| -52% | -$20.8M | 0.02% | 631 |
|
|
2022
Q4 | $42.4M | Buy |
162,800
+24,500
| +18% | +$6.57M | 0.05% | 393 |
|
|
2022
Q3 | $31.4M | Buy |
138,300
+35,700
| +35% | +$8.65M | 0.05% | 382 |
|
|
2022
Q2 | $25M | Buy |
102,600
+53,800
| +110% | +$13.2M | 0.04% | 505 |
|
|
2022
Q1 | $11.9M | Buy |
48,800
+25,100
| +106% | +$5.77M | 0.01% | 811 |
|
|
2021
Q4 | $5.36M | Buy |
23,700
+5,200
| +28% | +$1.1M | ﹤0.01% | 1225 |
|
|
2021
Q3 | $3.96M | Sell |
18,500
-4,200
| -19% | -$967K | ﹤0.01% | 1245 |
|
|
2021
Q2 | $5.54M | Sell |
22,700
-5,300
| -19% | -$1.3M | 0.01% | 1070 |
|
|
2021
Q1 | $6.94M | Sell |
28,000
-60,200
| -68% | -$14.4M | 0.01% | 905 |
|
|
2020
Q4 | $20.1M | Sell |
88,200
-5,800
| -6% | -$1.34M | 0.03% | 577 |
|
|
2020
Q3 | $23.9M | Sell |
94,000
-19,600
| -17% | -$4.86M | 0.04% | 411 |
|
|
2020
Q2 | $26.8M | Buy |
113,600
+1,100
| +1% | +$251K | 0.05% | 346 |
|
|
2020
Q1 | $22.9M | Sell |
112,500
-68,000
| -38% | -$14.9M | 0.05% | 328 |
|
|
2019
Q4 | $43.3M | Sell |
180,500
-27,500
| -13% | -$6.06M | 0.08% | 262 |
|
|
2019
Q3 | $40.3M | Buy |
208,000
+24,500
| +13% | +$4.7M | 0.08% | 282 |
|
|
2019
Q2 | $33.8M | Sell |
183,500
-65,400
| -26% | -$11.7M | 0.06% | 315 |
|
|
2019
Q1 | $47.3M | Sell |
248,900
-133,200
| -35% | -$25.4M | 0.09% | 237 |
|
|
2018
Q4 | $74.4M | Buy |
382,100
+33,200
| +10% | +$6.48M | 0.14% | 146 |
|
|
2018
Q3 | $72.3M | Buy |
348,900
+76,600
| +28% | +$15.1M | 0.12% | 170 |
|
|
2018
Q2 | $50.3M | Buy |
272,300
+12,900
| +5% | +$2.28M | 0.09% | 206 |
|
|
2018
Q1 | $44.2M | Buy |
+259,400
| New | +$47.6M | 0.07% | 288 |
|
|
2017
Q4 | – | Sell |
-204,100
| Closed | -$38.1M | – | 2039 |
|
|
2017
Q3 | $38.1M | Buy |
204,100
+25,300
| +14% | +$4.48M | 0.06% | 317 |
|
|
2017
Q2 | $30.8M | Buy |
178,800
+7,000
| +4% | +$1.14M | 0.06% | 358 |
|
|
2017
Q1 | $28.2M | Sell |
171,800
-48,000
| -22% | -$7.98M | 0.06% | 357 |
|
|
2016
Q4 | $32.1M | Sell |
219,800
-4,500
| -2% | -$677K | 0.08% | 305 |
|
|
2016
Q3 | $37.4M | Buy |
224,300
+39,600
| +21% | +$6.7M | 0.09% | 238 |
|
|
2016
Q2 | $28.1M | Sell |
184,700
-16,900
| -8% | -$2.63M | 0.08% | 310 |
|
|
2016
Q1 | $30.2M | Buy |
201,600
+25,400
| +14% | +$3.77M | 0.09% | 275 |
|
|
2015
Q4 | $28.6M | Buy |
176,200
+138,500
| +367% | +$21.8M | 0.07% | 329 |
|
|
2015
Q3 | $5.21M | Sell |
37,700
-14,255
| -27% | -$2.25M | 0.01% | 800 |
|
|
2015
Q2 | $7.98M | Sell |
51,955
-24,945
| -32% | -$4M | 0.02% | 694 |
|
|
2015
Q1 | $12.3M | Sell |
76,900
-91,300
| -54% | -$14.4M | 0.02% | 596 |
|
|
2014
Q4 | $26.8M | Buy |
168,200
+21,200
| +14% | +$3.3M | 0.06% | 368 |
|
|
2014
Q3 | $20.6M | Buy |
147,000
+5,500
| +4% | +$718K | 0.04% | 427 |
|
|
2014
Q2 | $16.8M | Buy |
141,500
+91,000
| +180% | +$10.5M | 0.04% | 459 |
|
|
2014
Q1 | $6.23M | Sell |
50,500
-168,500
| -77% | -$20.4M | 0.01% | 726 |
|
|
2013
Q4 | $25M | Buy |
219,000
+49,100
| +29% | +$5.59M | 0.07% | 342 |
|
|
2013
Q3 | $19M | Buy |
+169,900
| New | +$18.4M | 0.05% | 406 |
|
Other funds holding AMGN
VCM
VPM
HSBC Holdings's AMGN Position: Q1 2026 in Review
HSBC Holdings reduced its Amgen (AMGN) stake by 12% in Q1 2026, selling an estimated $66.3M and leaving 1,351,347 shares worth $476M. The position accounts for 0.25% of the portfolio, ranked #71.
HSBC Holdings first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $590M in Q2 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- HSBC Holdings held 1,351,347 shares of Amgen worth $476M as of Q1 2026.
- HSBC Holdings sold 185,904 Amgen shares in Q1 2026, an estimated $66.3M.
- Amgen made up 0.25% of HSBC Holdings's portfolio in Q1 2026, its #71 holding.
- HSBC Holdings first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Amgen position peaked at $590M in Q2 2024.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.